Home/Filings/4/0000899243-22-025361
4//SEC Filing

SHROFF ZUBEEN 4

Accession 0000899243-22-025361

CIK 0001596946other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:35 PM ET

Size

21.1 KB

Accession

0000899243-22-025361

Insider Transaction Report

Form 4
Period: 2022-06-24
SHROFF ZUBEEN
Director10% Owner
Transactions
  • Purchase

    Ordinary Shares

    2022-06-24$0.30/sh+4,666,666$1,400,00011,995,740 total(indirect: See footnote)
Holdings
  • Ordinary Shares Option (Right to buy)

    Exercise: $2.53Exp: 2031-10-31Ordinary Shares (24,040 underlying)
    24,040
  • Ordinary Shares Option (Right to buy)

    Exercise: $6.41Exp: 2028-10-31Ordinary Shares (6,240 underlying)
    6,240
  • Restricted Stock Units

    Ordinary Shares (2,668 underlying)
    5,336
  • Ordinary Shares Option (Right to buy)

    Exercise: $4.55Exp: 2030-10-31Ordinary Shares (13,611 underlying)
    13,611
  • Restricted Stock Units

    Ordinary Shares (10,870 underlying)
    21,738
  • Ordinary Shares

    118,461
  • Ordinary Shares Option (Right to buy)

    Exercise: $11.62Exp: 2025-10-31Ordinary Shares (7,505 underlying)
    7,505
  • Ordinary Shares Option (Right to buy)

    Exercise: $5.73Exp: 2026-10-31Ordinary Shares (8,726 underlying)
    8,726
  • Ordinary Shares Option (Right to buy)

    Exercise: $5.21Exp: 2027-10-31Ordinary Shares (9,597 underlying)
    9,597
  • Ordinary Shares Option (Right to buy)

    Exercise: $7.78Exp: 2029-10-31Ordinary Shares (8,158 underlying)
    8,158
  • Ordinary Shares Option (Right to buy)

    Exercise: $8.00Exp: 2024-04-29Ordinary Shares (5,000 underlying)
    5,000
  • Ordinary Shares Option (Right to buy)

    Exercise: $9.95Exp: 2024-10-31Ordinary Shares (5,025 underlying)
    5,025
Footnotes (14)
  • [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F10]All 13,611 options have vested and remain exercisable.
  • [F11]On October 31, 2021, the Reporting Person was granted 43,478 restricted stock units, of which 21,704 have vested and have converted into ordinary shares. The remaining 21,738 restricted stock units will vest in two equal installments on July 31, 2022 and October 31, 2022.
  • [F12]On October 31, 2021, the Reporting Person was granted 10,672 restricted stock units, of which 5,336 have vested and have converted into ordinary shares. The remaining 5,336 restricted stock units will vest in two equal installments on July 31, 2022 and October 31, 2022.
  • [F13]The options vest and become exercisable on October 31, 2022.
  • [F14]Galen Partners V LP acquired 4,299,501 ordinary shares and Galen Partners International V LP ("Galen International V") acquired 367,165 ordinary shares.
  • [F2]Includes 10,913,091 ordinary shares held of record by Galen V LP, 931,945 ordinary shares held by Galen International V LP, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V LP, Galen International V LP and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
  • [F3]All 7,505 options have vested and remain exercisable.
  • [F4]All 5,000 options have vested and remain exercisable.
  • [F5]All 5,025 options have vested and remain exercisable.
  • [F6]All 8,726 options have vested and remain exercisable.
  • [F7]All 9,597 options have vested and remain exercisable.
  • [F8]All 6,240 options have vested and remain exercisable.
  • [F9]2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001056630

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:35 PM ET
Size
21.1 KB